←
SCWD1,221 posts
SCWD avatar

SCWD

@SCWDnews

Driving Innovation in Research, Education and Clinical Excellence Worldwide #SCWDConference2026 10-12 Dec, 2026. Inperson | Washington, DC.

◷ Joined November 2015▧ 921 Photos and videos
SCWD avatar
SCWD@SCWDnews·9h

Cachexia extends well beyond cancer. In heart failure, type 2 diabetes, COPD and MASH/MASLD, chronic disease can be accompanied by profound changes in body composition and muscle health. Session 17 at SCWD 2026 brings these conditions into focus with a 2026 update on cachexia across chronic illness, highlighting where current evidence is taking clinical care. Join us in Washington, DC, 10–12 December 2026. Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #Cachexia #CancerCachexiaResearch #HeartFailure #Type2Diabetes #COPD #MASLD #MuscleWasting

Post attachment
SCWD avatar
SCWD@SCWDnews·12h

Protein intake is necessary but not sufficient for preserving muscle mass in sarcopenia and cachexia, the anabolic response depends on protein quality, timing, distribution and the metabolic context of the underlying disease. At SCWD 2026, I’ll be examining the evidence on nutritional strategies targeting muscle protein synthesis, with a focus on where current guidelines hold and where the data remains contested. Join me in Washington, DC for a discussion on how optimised protein nutrition integrates with multimodal intervention in sarcopenia and cachexia management. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #Sarcopenia #Cachexia #MuscleWasting #ProteinNutrition #ClinicalNutrition #NutritionalSupport #PatientOutcomes

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 16

The next generation of cancer cachexia therapies is moving from mechanistic hypothesis to clinical trial evidence and the questions around endpoints, target selection, and combination strategies are becoming sharper. Session 16 at #SCWD2026 examines what constitutes a relevant endpoint for cachexia trials, MC3/MC4R receptor inhibition as a therapeutic approach, GDF-15 inhibition to reduce cachexia and promote anti-tumour immunity, and s-pindolol as an emerging pharmacological strategy. Hear from experts including Prof. Dr. Stefan D. Anker, Prof. Dan Marks, Prof. Eric Roeland and Prof. Andrew Coats as they discuss therapeutic strategies being investigated for cancer cachexia. Join us in Washington, DC, 10–12 December 2026. Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #CancerCachexia #Cachexia #ClinicalTrials #EmergingTherapies #MuscleWasting

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 16

Developing a therapy or diagnostic biomarker for cancer cachexia? Join the experts and regulators shaping the path to approval. At the SCWD Regulatory & Trials Update Workshop, academic experts, regulators and industry representatives will tackle the key questions in cancer cachexia trials: - Which endpoints are approvable: 6-minute walk, SPPB or survival? - Which patient-reported outcomes count: PROMIS Physical Function, EORTC QLQ-C30 or the FAACT anorexia score? - Who qualifies as “cachectic” for diagnosis and trial inclusion? - Are nutrition and exercise needed as background therapy? - Could cancer cachexia be an orphan disease? Wednesday, December 9, 2026 · 15:20–18:45 Marriott Georgetown, Washington, DC, and online Interested in joining? Contact us: lnkd.in/g4vgwd8Y #SCWD2026 #CancerCachexia #Oncology #ClinicalTrials #Biomarkers #RegulatoryScience

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 14

Understanding the mechanisms of cancer cachexia and muscle wasting is essential to advancing research and improving care for affected patients. Join Prof. Teresa Zimmers, Co-Chair of the 19th International Conference on Sarcopenia, Cachexia & Wasting Disorders and connect with 350+ international community of clinicians and researchers to advance muscle wasting research and improve patient outcomes. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #CancerCachexia #Cachexia #MuscleWasting #TranslationalResearch #BasicScience #ClinicalResearch #PatientOutcomes

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 13

What can biomarkers and molecular mechanisms reveal about the biology and progression of cancer cachexia? Session 15 at #SCWD2026 examines JAK1/2 inhibition and its effects on cachexia and survival, responder analysis from the PACTO trial, GDF-15 as a biomarker of cancer cachexia, and BMP7 as a potential master regulator of gastric cancer-associated cachexia. A translational session connecting circulating biomarkers and intracellular signalling pathways to the clinical reality of cachexia progression and treatment response. Join us in Washington, DC, 10–12 December 2026. Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #CancerCachexia #Cachexia #Biomarkers #MuscleWasting #TranslationalResearch

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 12

Cancer cachexia requires more than nutritional support, it demands integrated, multimodal approaches across the entire patient journey. Session 13 at #SCWD2026 brings clinical perspectives together through COACH-ED, examining diagnosis and management in oncology and palliative care, nutritional interventions in multimodal cachexia management including innovation in clinical trials. Featuring Prof. Paula Ravasco, Priv.-Doz. Dr. Uwe Pelzer, and Prof. Jose Garcia, a clinically grounded session on what it takes to translate cachexia science into practice. Join us in Washington, DC | 10–12 December 2026 Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #CancerCachexia #Cachexia #Nutrition #Oncology #PalliativeCare #ClinicalTrials #COACHED

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 10

Planning a clinical trial in sarcopenia, frailty or ageing? Bring your questions to the experts and the regulators. At the SCWD Regulatory & Trials Update Workshop, leading researchers, EMA and FDA representatives, and industry will work through the questions that shape sarcopenia trials: - Which endpoints are approvable? - BIA, DEXA, CT or MRI: how should muscle mass be measured? - SPPB, 6-minute walk, physical activity: which functional assessments matter? Wednesday, December 9, 2026 · 13:00–15:00 Marriott Georgetown, Washington, DC, and online Interested in joining? Contact us: society-scwd.org/contact-pag… #SCWD2026 #Sarcopenia #ClinicalTrials #RegulatoryScience #Ageing #Frailty

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 9

Incretin-based therapies are being studied across multiple organ systems, extending the clinical discussion beyond weight loss. I’m Henning Langer, and at SCWD 2026, I’ll discuss the effects of incretin treatment, not just on the liver and heart but on the bone too. A closer look at multi-organ effects as research continues to define the wider implications of incretin-based therapies. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch #IncretinTherapies #BoneHealth #LiverHealth #CardiovascularHealth #MuscleWasting #ClinicalManagement #PatientCare

Post attachment
SCWD avatar
SCWD@SCWDnews·Nov 4

Cachexia does not stop at the muscle, and critical illness accelerates wasting across multiple organ systems simultaneously. Session 12 at #SCWD2026 examines cachexia across distinct critical illness contexts: chronic kidney disease, type 2 diabetes, sepsis, and liver growth and injury. Each presents a different mechanistic and clinical picture, but shared pathways in systemic wasting connect them. Join this translational session examining how disease-specific drivers of cachexia converge, and what that means for understanding and intervening in muscle loss in critically ill patients. Join us in Washington, DC, 10–12 December 2026. Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #Cachexia #CancerCachexiaResearch #MuscleWasting #CriticalIllness #Sepsis #KidneyDisease #TranslationalResearch

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 31

Incretin-based therapies are changing how we approach weight management, but their effects extend beyond changes in body weight. At SCWD 2026, we’ll discuss multi-organ wasting during incretin treatment, with a focus on muscle health and the broader effects of these therapies across skeletal muscle and other organs. A clinically focused discussion at the intersection of sarcopenia, adiposity and cardiometabolic disease, and what these considerations mean for patient care. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResarch #Sarcopenia #IncretinTherapies #MuscleWasting #MuscleHealth #Adiposity #CardiometabolicHealth #ClinicalManagement

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 29

Cancer cachexia remains an important clinical consideration in oncology, affecting up to 80% of advanced cancer patients. I’m Jeffrey Crawford, and at SCWD 2026, I’ll deliver the “Hippocrates” Clinical Science Keynote Lecture, sharing an oncologist’s perspective on cancer and cachexia and the importance of recognising its clinical impact. I look forward to discussing how greater understanding of cachexia can support clinical management and better patient outcomes. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResarch #CancerCachexia #Cachexia #Oncology #ClinicalScience #ClinicalManagement #PatientOutcomes

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 28

Metabolic pathways may offer new insights into the relationship between bone and muscle health. Join Prof. Gustavo Duque at SCWD 2026 for “Tryptophan Metabolites as Regulators of Bone and Muscle Health”, examining how tryptophan metabolites may influence bone-muscle biology in sarcopenia and osteosarcopenia. Part of a multidisciplinary programme advancing basic and clinical science to inform better patient care. 10–12 December 2026 | Washington, DC Register: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #CancerCachexiaResarch #Sarcopenia #Osteosarcopenia #BoneHealth #MuscleHealth #TryptophanMetabolism #BasicScience #PatientCare

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 27

How can anorexia and cachexia be managed more effectively in patients with cancer? At ESMO 2026, multimodal interventions for anorexia and cachexia highlight the need to address nutritional intake, muscle loss, weight loss and declining physical function alongside cancer treatment. At SCWD 2026, basic and clinical science come together to examine the mechanisms of cancer cachexia and translate research into clinical care, with a focus on advancing research for better patient care. Continue the discussion at the 19th International Conference on Sarcopenia, Cachexia & Wasting Disorders, 10–12 December 2026 in Washington, DC. Register now: tinyurl.com/y964em5h #CancerCachexia #ESMO2026 #OncologyResearch #MuscleWasting #Nutrition #SCWD2026 #SCWDConference2026 #CancerCachexiaResearch

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 24

Muscle mass tells only part of the story. Session 10 at SCWD 2026 examines the relationship between muscle biology, quality and function in cancer cachexia, drawing on preclinical and clinical insights into functional decline, recovery and muscle remodelling. Research to Care takes centre stage as experts consider what muscle measurements mean for real-world function and advanced patient outcomes. Join us in Washington, DC, 10–12 December 2026. Register early: tinyurl.com/y964em5h #SCWD2026 #SCWDConference2026 #Cachexia #CancerCachexiaResarch #MuscleWasting #MuscleQuality #MuscleFunction #TranslationalResearch

Post attachment
SCWD avatar
SCWD@SCWDnews·Oct 21

Cachexia involves systemic changes that extend beyond skeletal muscle, with multiple organs contributing to disease progression and wasting. Join Prof. Marilia Seelaender at SCWD 2026 for “Cachexia as a Multi-Organ Disease”, where she will examine the interactions between organs that contribute to cachexia and their relevance to research and patient care. Connect with a global community advancing research and clinical excellence in cachexia, sarcopenia and wasting disorders. 10–12 December 2026 | Washington, DC Register now: tinyurl.com/27j2btxt #SCWD2026 #SCWDConference2026 #CancerCachexiaResarch #Cachexia #CancerCachexia #MuscleWasting #MultiOrganDisease #PatientCare

Post attachment